What is NDC 27241-134?

27241-134 is the product NDC for Cholestyramine, Cholestyramine 4 g/9g powder, for suspension, listed with the FDA by Ajanta Pharma USA Inc.. It has 2 package NDCs, shown above in 10- and 11-digit form.

Ajanta Pharma USA Inc., NDC labeler code 27241. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Cholestyramine?

21 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Cholestyramine NDC 27241-134 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)27241-134Labeler and product segments. Claims need a package NDC.

Product NDC at billing width27241-0134Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
27241-134-36	2724101343627241013436	60 PACKET in 1 CARTON (27241-134-36) / 9 g in 1 PACKET (27241-134-21)Marketed from Apr 6, 2020
27241-134-51	2724101345127241013451	378 g in 1 BOTTLE (27241-134-51)Marketed from Apr 6, 2020

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Cholestyramine
Generic name (nonproprietary): cholestyramine
Active ingredients: Cholestyramine — 4 g/9g
Dosage form: Powder, For suspension
Route: Oral
Labeler: Ajanta Pharma USA Inc.NDC labeler code 27241
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 211119
Marketing start: Apr 6, 2020
Listing expires: Dec 31, 2026
Other FDA classes: Bile-acid Binding Activity (Mechanism)
Identifiers: Product ID 27241-134_52a1ce3a-88e1-4902-990d-c57cf9735e42SPL ID 52a1ce3a-88e1-4902-990d-c57cf9735e42SPL set ID a0b64dfe-49bc-45d7-9281-9e9d6e296c40RxCUI 848943UNII 4B33BGI082UPC 0327241134210, 0327241134517
Pharmacologic class: Bile Acid Sequestrant

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N427241013436 followed by a unit qualifier and the quantity

Package 27241-0134-36. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Oct 8, 2025.

Indications (excerpt from the label)

INDICATIONS & USAGE 1) Cholestyramine for oral suspension, USP is indicated as adjunctive therapy to diet for the reduction of elevated serum cholesterol in patients with primary hypercholesterolemia (elevated low density lipoprotein [LDL] cholesterol) who do not respond adequately to diet. Cholestyramine for oral suspension, USP may be useful to lower LDL cholesterol in patients who also have hypertriglyceridemia, but it is not indicated where hypertriglyceridemia is the abnormality of most concern. Therapy with lipid-altering agents should be a component of multiple risk factor intervention in those individuals at significantly increased risk for atherosclerotic vascular disease due to hyp…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 27241-134

What is NDC 27241-134?: 27241-134 is the product NDC for Cholestyramine, Cholestyramine 4 g/9g powder, for suspension, listed with the FDA by Ajanta Pharma USA Inc.. It has 2 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Cholestyramine.
What is the active ingredient?: Cholestyramine.
Who is the labeler?: Ajanta Pharma USA Inc., NDC labeler code 27241. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Cholestyramine?: 21 other product NDCs are listed under this name. See all Cholestyramine NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Cholestyramine NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Cholestyramine	Cholestyramine 4 g/9g	Powder, For suspensionOral	AiPing Pharmaceutical, Inc.	11788-150	11788-0150-1711788-0150-60
Cholestyramine	Cholestyramine 4 g/9g	Powder, For suspensionOral	Micro Labs Limited	42571-508	42571-0508-29
Cholestyramine	Cholestyramine 4 g/9g	Powder, For suspensionOral	Macleods Pharmaceuticals Limited	33342-293	33342-0293-7033342-0293-71
Cholestyramine	Cholestyramine 4 g/5.7g	Powder, For suspensionOral	Macleods Pharmaceuticals Limited	33342-319	33342-0319-7033342-0319-7233342-0319-83
Cholestyramine	Cholestyramine 4 g/9g	Powder, For suspensionOral	Precision Dose, Inc.	68094-806	68094-0806-1068094-0806-20
Cholestyramine	Cholestyramine 4 g/4.8g	Powder, For suspensionOral	Precision Dose, Inc.	68094-906	68094-0906-1068094-0906-20
Cholestyramine	Cholestyramine 4 g/9g	Powder, For suspensionOral	PURACAP LABORATORIES LLC DBA BLU PHARMACEUTICALS	24658-266	24658-0266-9324658-0266-9524658-0266-97
Cholestyramine	Cholestyramine 4 g/9g	Powder, For suspensionOral	EPIC PHARMA, LLC	42806-265	42806-0265-98
Cholestyramine	Cholestyramine 4 g/9g	Powder, For suspensionOral	EPIC PHARMA, LLC	42806-266	42806-0266-95
Cholestyramine	Cholestyramine 4 g/9g	Powder, For suspensionOral	EPIC PHARMA, LLC	42806-267	42806-0267-9342806-0267-97

All 22 Cholestyramine NDCs